Partial Opioid Agonist drugs compared
Compare all 4 Partial Opioid Agonist drugs side by side, used for conditions such as heroin dependence, pain. They share one FDA-defined mechanism but differ in approved uses, prescription status, brand-vs-generic options, price, and FDA recall-safety record — which our independent rating scores.
Full ranking · 4 drugs
- 172/100
buprenorphine hydrochloride
Buprenorphine Hydrochloride
- 2New
belbuca
Buprenorphine Hydrochloride
- 3New
brixadi
Buprenorphine
- 4New
sublocade
Buprenorphine
Frequently asked questions
What is the Partial Opioid Agonist drug class?
Partial Opioid Agonist is an FDA Established Pharmacologic Class (EPC) — a group of drugs that share a mechanism of action. pharmaranks lists 4 Partial Opioid Agonist products, each independently rated.
Are all Partial Opioid Agonist drugs the same?
No. Partial Opioid Agonist drugs share the same core mechanism — that is why they sit in one FDA class — but they differ in their approved uses, available forms, whether they are prescription or over-the-counter, brand-vs-generic options and price, and their FDA recall-safety record.
What conditions do Partial Opioid Agonist drugs treat?
Per NIH RxClass drug-classification data, Partial Opioid Agonist drugs are used for conditions including heroin dependence, pain.
Sources: the Partial Opioid Agonist class definition and its member drugs come from the U.S. NLM RxClass (Established Pharmacologic Class). Ratings are pharmaranks’ independent FDA recall-safety analysis.